Pro Share Advisors LLC Acadia Pharmaceuticals Inc Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Pro Share Advisors LLC holds 32,416 shares of ACAD stock, worth $527,408. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,416

Previous 26,626 21.75%

Holding current value

$527,408

Previous $432,000 15.28%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$15.14 - $19.14 $87,660 - $110,820	5,790 Added 21.75%	32,416 $498,000
Q2 2024 Aug 13, 2024	SELL	$14.62 - $18.42 $101,711 - $128,147	-6,957 Reduced 20.72%	26,626 $432,000
Q1 2024 May 08, 2024	BUY	$17.79 - $30.86 $54,223 - $94,061	3,048 Added 9.98%	33,583 $620,000
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $84,823 - $129,685	4,082 Added 15.43%	30,535 $956,000
Q3 2023 Nov 13, 2023	BUY	$20.84 - $33.47 $3,521 - $5,656	169 Added 0.64%	26,453 $551,000
Q2 2023 Aug 10, 2023	BUY	$17.8 - $25.65 $15,788 - $22,751	887 Added 3.49%	26,284 $629,000
Q1 2023 May 11, 2023	SELL	$16.32 - $20.92 $56,548 - $72,487	-3,465 Reduced 12.01%	25,397 $477,000
Q4 2022 Feb 02, 2023	BUY	$14.2 - $18.63 $28,300 - $37,129	1,993 Added 7.42%	28,862 $459,000
Q3 2022 Nov 04, 2022	SELL	$14.11 - $18.27 $16,071 - $20,809	-1,139 Reduced 4.07%	26,869 $440,000
Q2 2022 Aug 01, 2022	SELL	$13.01 - $27.22 $178,523 - $373,512	-13,722 Reduced 32.88%	28,008 $395,000
Q1 2022 May 10, 2022	SELL	$20.94 - $27.5 $209,588 - $275,247	-10,009 Reduced 19.35%	41,730 $1.01 Million
Q4 2021 Feb 08, 2022	SELL	$16.79 - $27.09 $11,568 - $18,665	-689 Reduced 1.31%	51,739 $1.21 Million
Q3 2021 Nov 12, 2021	SELL	$15.78 - $24.77 $183,521 - $288,075	-11,630 Reduced 18.16%	52,428 $871,000
Q2 2021 Aug 13, 2021	BUY	$19.4 - $27.42 $770,548 - $1.09 Million	39,719 Added 163.19%	64,058 $1.56 Million
Q1 2021 May 14, 2021	SELL	$25.02 - $54.99 $57,020 - $125,322	-2,279 Reduced 8.56%	24,339 $628,000
Q4 2020 Feb 09, 2021	SELL	$41.04 - $56.79 $32,134 - $44,466	-783 Reduced 2.86%	26,618 $1.42 Million
Q3 2020 Nov 13, 2020	BUY	$36.42 - $57.0 $24,328 - $38,076	668 Added 2.5%	27,401 $1.13 Million
Q2 2020 Aug 03, 2020	SELL	$39.26 - $52.73 $121,509 - $163,199	-3,095 Reduced 10.38%	26,733 $1.3 Million
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $678,132 - $1 Million	-21,426 Reduced 41.8%	29,828 $1.26 Million
Q4 2019 Feb 12, 2020	SELL	$36.21 - $51.4 $84,333 - $119,710	-2,329 Reduced 4.35%	51,254 $2.19 Million
Q3 2019 Nov 12, 2019	SELL	$22.22 - $44.01 $71,503 - $141,624	-3,218 Reduced 5.67%	53,583 $1.93 Million
Q2 2019 Aug 13, 2019	SELL	$23.32 - $28.12 $207,408 - $250,099	-8,894 Reduced 13.54%	56,801 $1.52 Million
Q1 2019 May 15, 2019	BUY	$16.17 - $27.38 $67,833 - $114,859	4,195 Added 6.82%	65,695 $1.76 Million
Q4 2018 Feb 14, 2019	SELL	$14.32 - $22.92 $71,027 - $113,683	-4,960 Reduced 7.46%	61,500 $994,000
Q3 2018 Nov 14, 2018	SELL	$13.03 - $21.81 $17,108 - $28,636	-1,313 Reduced 1.94%	66,460 $1.38 Million
Q2 2018 Aug 13, 2018	BUY	$15.07 - $22.34 $114,471 - $169,694	7,596 Added 12.62%	67,773 $1.04 Million
Q1 2018 May 14, 2018	SELL	$22.47 - $32.33 $210,903 - $303,449	-9,386 Reduced 13.49%	60,177 $1.35 Million
Q4 2017 Feb 14, 2018	SELL	$26.84 - $39.14 $45,144 - $65,833	-1,682 Reduced 2.36%	69,563 $2.1 Million
Q3 2017 Nov 13, 2017	BUY	$29.49 - $38.37 $194,634 - $253,241	6,600 Added 10.21%	71,245 $2.68 Million
Q2 2017 Aug 11, 2017	BUY	N/A	64,645	64,645 $1.8 Million

Others Institutions Holding ACAD

# of Institutions

280

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Acadia Pharmaceuticals Inc Transaction History